title: Re: Fei Y, Guyatt GH, Alexander PE, et al. Addition of ezetimibe to statins for patients at high cardiovascular risk: Systematic review of patient-important outcomes. J Eval Clin Pract.
authors.affiliation: Therapeutics Initiative, University of British Columbia, Vancouver, Canada.
authors.forename: Cait S E
authors.initials: CSE
authors.lastname: O'Sullivan
authors.affiliation: Therapeutics Initiative, University of British Columbia, Vancouver, Canada.
authors.forename: Aaron M
authors.identifier: 0000-0001-5496-1470
authors.initials: AM
authors.lastname: Tejani
mesh_terms: D002318:Cardiovascular Diseases; D000069438:Ezetimibe; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D012307:Risk Factors
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000069438:Ezetimibe